Log in

Start Your Membership Now

On January 26, 2022, Akili Interactive, which develops digital health technology to treat cognitive impairments, announced it entered into an agreement to become publicly traded via a merger with Social Capital Suvretta Holdings Corp. I (SCS), a special purpose acquisition company (SPAC). The proposed combination has been unanimously approved by the boards of directors of both Akili and SCS and is expected to close in mid-2022. Once the deal closes, Akili will become part of SCS, which is a publicly traded company.

After the transaction is complete, Akili intends to launch commercial sales of its flagship product, EndeavorRx® a . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: